COHEN YUVAL (Chief Executive Officer) sold 9.8% of their position (17K shares) of CORBUS PHARMACEUTICALS HOLDINGS, INC. on the open market
Open‑market sale worth $171.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/10/2026ACC: 0001193125-26-342485
DirectorOfficer· Chief Executive Officer
Since Jan 2019
-17K
Net shares
Net seller
$171.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
17K disposed
Non-Derivative Transactions1
Common Stock, par value $0.0001 per share
Direct
Shares
−17K
Price / share
$10.08
Trade value
$171.40K
% of position
9.8%
8/7/2026
174.32K→157.32K
Total
Net shares
−17K
Net value
-$171.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Direct | 8/7/2026 | S · Sale | −17K | $10.08 | $171.40K | 9.8% | 174.32K | 157.32K |
| Total | −17K | -$171.40K | ||||||
Derivative Transactions0
No derivative transactions reported